Lead BET Inhibitor, VYN201, Significantly Reduces Expression of Several Key Pro-Inflammatory Cytokines in Preclinical Studies
VYNE Therapeutics Inc.
Tue, October 26, 2021, 8:00 PM · 8 min read
In this article:
Lead BET Inhibitor, VYN201, Significantly Reduces Expression of Several Key Pro-Inflammatory Cytokines in Preclinical Studies
VYNE Therapeutics Inc.
Tue, October 26, 2021, 8:00 PM · 8 min read
In this article:
精彩评论